School of Public Health and Community Medicine, the University of New South Wales, Sydney, Australia.
Crit Care Med. 2012 Feb;40(2):388-93. doi: 10.1097/CCM.0b013e318232e4f3.
Identify the longest period a central line remains free from central line-associated bloodstream infection during an 18-month insertion-bundle project.
Prospective cohort.
New South Wales adult intensive care units at university teaching hospitals between July 2007 and December 2008.
Intensive care unit adult patients whose central line was inserted in the intensive care unit.
Compliance with the insertion bundle for central lines during the first 12-month roll-out period and the last 6 months.
The cumulative line days that remained close to infection-free before the lowest probability of central line-associated bloodstream infection, 1 in 100 chances, was identified using conditional probability modeling. An adjusted central line-associated bloodstream infection rate was calculated for these cumulated line days and thereafter where the probability for infection increased with additional dwell time.
The lowest probability identified for central line-associated bloodstream infection was 1 in 100 chances regardless of the phase of the project or central line type. During the first 12 months of the project, the close to infection-free period finished by the end of day 7 giving an adjusted central line-associated bloodstream infection rate of 1.8 (95% confidence interval 0.9-3.3)/1000 line days. By the last 6 months of the project the close to infection-free period was extended by 2 additional line days to the end of day 9, giving an adjusted central line-associated bloodstream infection rate of 0.9 (95% confidence interval 0.5-1.5)/1,000 line days. For dialysis and unspecified central line types, the close to infection-free period was extended by 5 additional line days, from day 2 with a rate of 4.3 (95% confidence interval 0.9-12.5)/1,000 line days to day 7, giving a rate of 0.6 (95% confidence interval 0.2-2.4)/1,000 line days.
The success of the insertion bundle was identified by improved analysis that identified that the safest dwell time was extended to the first 9 days for centrally inserted lines and up to day 7 for dialysis, peripherally inserted central catheters, and unspecified central line types. Given that three quarters of intensive care unit patients have their central line removed by day 7, zero risk for central line-associated bloodstream infection should be achievable in the majority of patients where clinicians comply with the clinician and patient insertion bundles.
确定在 18 个月的中央导管插入套件项目中,中央导管最长的无导管相关血流感染时间。
前瞻性队列研究。
2007 年 7 月至 2008 年 12 月期间,新南威尔士州大学教学医院的成人重症监护病房。
重症监护病房成人患者,其中央导管在重症监护病房中插入。
在最初 12 个月的推出阶段和最后 6 个月内遵守中央导管插入套件。
使用条件概率建模确定,在感染概率最低的情况下(1/100 机会),累积的接近无感染的导管天数。在这些累积的导管天数之后,以及随着留置时间的增加感染概率增加的情况下,计算了调整后的导管相关血流感染率。
无论项目阶段或中央导管类型如何,确定的导管相关血流感染的最低概率为 1/100 机会。在项目的前 12 个月中,接近无感染期在第 7 天结束时结束,调整后的导管相关血流感染率为 1.8(95%置信区间 0.9-3.3)/1000 导管天。在项目的最后 6 个月中,接近无感染期通过在第 9 天结束时增加 2 个额外的导管天而延长,调整后的导管相关血流感染率为 0.9(95%置信区间 0.5-1.5)/1000 导管天。对于透析和未指定的中央导管类型,无感染期通过在第 2 天增加 5 个额外的导管天延长至第 7 天,感染率为 4.3(95%置信区间 0.9-12.5)/1000 导管天,调整后的感染率为 0.6(95%置信区间 0.2-2.4)/1000 导管天。
通过改进的分析,识别出中央插入导管的最安全留置时间延长至第 9 天,而透析、外周插入中心导管和未指定的中央导管类型的最安全留置时间延长至第 7 天,从而确定插入套件的成功。鉴于四分之三的重症监护病房患者在第 7 天前拔除中央导管,只要临床医生遵守临床医生和患者插入套件,大多数患者都可以实现中央导管相关血流感染的零风险。